Search results for "estrògens"

showing 4 items of 4 documents

A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer

2019

No luminal; Subtipus intrínsec; Càncer de mama No luminal; Subtipo intrínseco; Cáncer de mama Non-luminal; Intrinsic subtype, Breast cancer Background: In hormone receptor-positive (HR+)/HER2-negative breast cancer, the HER2-enriched and Basal-like intrinsic subtypes are associated with poor outcome, low response to anti-estrogen therapy and high response to chemotherapy. To date, no validated biomarker exists to identify both molecular entities other than gene expression. Methods: PAM50 subtyping and immunohistochemical data were obtained from 8 independent studies of 1,416 HR+/HER2-negative early breast tumors. A non-luminal disease score (NOLUS) from 0 to 100, based on percentage of estr…

0301 basic medicineCancer Researchmedicine.medical_specialtyintrinsic subtype:Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES]:Genetic Phenomena::Gene Expression Regulation::Gene Expression Regulation Neoplastic [PHENOMENA AND PROCESSES]medicine.medical_treatmentEstrogen receptor:fenómenos genéticos::regulación de la expresión génica::regulación de la expresión génica neoplásica [FENÓMENOS Y PROCESOS]:aminoácidos péptidos y proteínas::proteínas::receptores citoplásmicos y nucleares::receptores de esteroides::receptores de estrógenos [COMPUESTOS QUÍMICOS Y DROGAS]lcsh:RC254-282Gastroenterology03 medical and health sciencesbreast cancer0302 clinical medicineBreast cancerMama - CàncerInternal medicineRegulació genèticaProgesterone receptorMedicinePAM50Original Research:neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES]Chemotherapynon-luminalbusiness.industry:Amino Acids Peptides and Proteins::Proteins::Receptors Cytoplasmic and Nuclear::Receptors Steroid::Receptors Estrogen [CHEMICALS AND DRUGS]lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.disease030104 developmental biologyEstrògens - ReceptorsOncologyHormone receptor030220 oncology & carcinogenesisCohortgene expressionBiomarker (medicine)ImmunohistochemistrybusinessFrontiers in Oncology
researchProduct

Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts

2018

Source at https://doi.org/10.1186/s13058-018-1073-0. Licensed CC BY-NC-ND 4.0. Background: Few published breast cancer (BC) risk prediction models consider the heterogeneity of predictor variables between estrogen-receptor positive (ER+) and negative (ER-) tumors. Using data from two large cohorts, we examined whether modeling this heterogeneity could improve prediction. Methods: We built two models, for ER+ (ModelER+) and ER- tumors (ModelER-) , respectively, in 281,330 women (51% postmenopausal at recruitment) from the European Prospective Investigation into Cancer and Nutrition cohort. Discrimination (C-statistic) and calibration (the agreement between predicted and observed tumor risks)…

OncologyHORMONE-REPLACEMENT THERAPYmedicine.medical_treatmentWHI0302 clinical medicineBreast cancerRisk FactorsEstrogen receptor030212 general & internal medicineProspective StudiesProspective cohort study2. Zero hungerIncidenceHormone replacement therapy (menopause)Middle Agedlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensPrognosisRisk prediction3. Good healthEuropean Prospective Investigation into Cancer and NutritionMenopausePOSTMENOPAUSAL WOMENReceptors EstrogenPLUS PROGESTIN030220 oncology & carcinogenesisCohortFemaleRisk assessmentResearch Articlemedicine.medical_specialtyMODELSAntineoplastic AgentsBreast NeoplasmsEstrògenslcsh:RC254-282Models BiologicalRisk AssessmentVALIDATIONCàncer de mamaMAMMOGRAPHY03 medical and health sciencesBreast cancerInternal medicinemedicineHumansOncology & CarcinogenesisCancer och onkologiVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Oncology: 762business.industryMORTALITYKirurgiProspective cohortmedicine.diseaseEstrogenVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762Cancer and OncologySurgerybusinessEPIC1112 Oncology And CarcinogenesisBody mass indexFollow-Up StudiesBreast Cancer Research : BCR
researchProduct

Efecto de las ciclooxigenasas en la biodisponibilidad del óxido nítrico en la respuesta vascular al tromboxano A2 en un modelo murino de envejecimien…

2018

El envejecimiento y la pérdida de los estrógenos durante la menopausia se asocian a una menor biodisponibilidad del NO, un aumento de los niveles de O2- vascular y un incremento de sustancias contráctiles, entre ellas el TXA2. Queda por determinar si los efectos deletéreos vasculares inducidos por el TXA2 durante el envejecimiento median una disminución en la biodisponibilidad de NO y un aumento en la producción de O2- y si están modulados por estrógenos. Para ello, se validó un modelo de envejecimiento vascular en ratonas con senescencia acelerada (SAM), con ratonas de la cepa SAMP8 con predisposición a la senescencia acelerada y ratonas SAMR1, con resistencia al desarrollo de senescencia …

ciclooxigenasaUNESCO::CIENCIAS MÉDICAS ::Farmacodinámica::Mecanismos de acción de los medicamentosUNESCO::CIENCIAS DE LA VIDA::Biología molecularanió superòxiddisfunció endotelialmenopausaenvellimentsamp8:CIENCIAS DE LA VIDA::Biología molecular [UNESCO]:CIENCIAS DE LA VIDA::Fisiología humana ::Fisiología cardiovascular [UNESCO]UNESCO::CIENCIAS DE LA VIDA::Fisiología humana ::Fisiología cardiovascularòxid nítricestrògens:CIENCIAS MÉDICAS ::Farmacodinámica::Mecanismos de acción de los medicamentos [UNESCO]
researchProduct

In utero exposure to mixtures of xenoestrogens and child neuropsychological development.

2014

BACKGROUND: To date, no epidemiological studies have explored the impact and persistence of in utero exposure to mixtures of xenoestrogens on the developing brain. We aimed to assess whether the cumulative effect of xenoestrogens in the placenta is associated with altered infant neuropsychological functioning at two and at four years of age, and if associations differ among boys and girls. METHODS: Cumulative prenatal exposure to xenoestrogens was quantified in the placenta using the biomarker Total Effective Xenoestrogen Burden (TEXB-alpha) in 489 participants from the INMA (Childhood and the Environment) Project. TEXB-alpha was split in tertiles to test its association with the mental and…

medicine.medical_specialty010501 environmental sciencesNeuropsychological Tests01 natural sciencesBiochemistryBayley Scales of Infant DevelopmentXenobioticsToxicology03 medical and health scienceschemistry.chemical_compoundPregnancyEpidemiologyMedicineHumansXenobiòtics -- ToxicologiaTests neuropsicològicsMotor skill030304 developmental biology0105 earth and related environmental sciencesGeneral Environmental SciencePsychomotor learning0303 health sciencesbusiness.industryConfoundingNeuropsychologyCognitionEstrogens3. Good healthXenoestrogenchemistryChild PreschoolPrenatal Exposure Delayed EffectsFemalebusinessEmbaràs--ComplicacionsClinical psychologyEstrògens -- ToxicologiaEnvironmental research
researchProduct